#biotech-startup

#biotech-startup

The biochemist revealed his results on February 2 on Spain's most-watched television program, El Hormiguero. The host, Pablo Motos, proclaimed: It's a miracle. Colleagues at his own center criticize Barbacid for not better explaining his conflict of interest. He and his colleagues Carmen Guerra and Vasiliki Liaki have applied for a patent for the commercial exploitation of their experimental therapy, should it ever become a reality.